Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Leukemia, Myeloid, Acute 55Multiple Myeloma 53Hodgkin Disease 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Lymphoma, Non-Hodgkin 46Leukemia, Lymphocytic, Chronic, B-Cell 44Myelodysplastic Syndromes 41Lymphoma, Mantle-Cell 39Lymphoma, Large B-Cell, Diffuse 38Lymphoma, Follicular 36Leukemia 36Congenital Abnormalities 36Burkitt Lymphoma 34Myeloproliferative Disorders 31Lymphoma 30Lymphoma, B-Cell, Marginal Zone 29Lymphoma, Large-Cell, Immunoblastic 28Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 25Blast Crisis 25Leukemia, Myelomonocytic, Chronic 24Recurrence 19Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 19Neoplasms, Plasma Cell 18Lymphoma, Large-Cell, Anaplastic 18Myelodysplastic-Myeloproliferative Diseases 16Sezary Syndrome 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15

Interventions

Ifosfamide 6X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Filgrastim 5Etoposide 5Doxorubicin 5Cyclophosphamide 5Vincristine 4Temozolomide 4Specimen Handling 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Melphalan 4Thiotepa 3Irinotecan 3Biopsy 3Bevacizumab 3ulixertinib 2trioctyl phosphine oxide 2tipifarnib 2temsirolimus 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2cixutumumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neuroectodermal Tumors, Primitive, Peripheral × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00002601 2017-03-03

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

City of Hope Medical Center

Phase 2 Completed
13 enrolled 8 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00357396 2015-11-25

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
10 enrolled 7 charts
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡